All Stories

  1. Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions
  2. Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP
  3. Structure of human drug transporters OATP1B1 and OATP1B3
  4. Transporters for Bile Formation in Physiology and Pathophysiology
  5. Cloning and characterization of a novel functional organic anion transporting polypeptide 3A1 isoform highly expressed in the human brain and testis
  6. Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver
  7. Glucose Transporter 9 (GLUT9) Plays an Important Role in the Placental Uric Acid Transport System
  8. Bioorthogonal site-selective conjugation of fluorescent dyes to antibodies: method and potential applications
  9. In Memoriam: Peter J. Meier (1947–2021)
  10. In memoriam Peter Meier-Abt 1947 -2021
  11. Structures of ABCB4 provide insight into phosphatidylcholine translocation
  12. Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice
  13. Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
  14. Comment on “Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model”
  15. Membrane lipids and transporter function
  16. Bile formation in long-term ex situ perfused livers
  17. Untargeted Metabolomics Reveals Anaerobic Glycolysis as a Novel Target of the Hepatotoxic Antidepressant Nefazodone
  18. Structure of the human lipid exporter ABCB4 in a lipid environment
  19. Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [11C]Tariquidar and PET in Humans and Mice
  20. microRNA‐206 modulates the hepatic expression of the organic anion‐transporting polypeptide 1B1
  21. Human MRP2 exports MC-LR but not the glutathione conjugate
  22. A rare cause of a cholestatic jaundice in a North African teenager
  23. Interaction of Local Anesthetics with Hepatocellular Organic Anion Transporting Polypeptides
  24. Organic anion‑transporting polypeptides contribute to the uptake of curcumin and its main metabolites by human breast cancer cells: Impact on antitumor activity
  25. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications
  26. Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients
  27. Imaging techniques to study drug transporter function in vivo
  28. Age‐dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human livers
  29. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease
  30. Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine
  31. β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine
  32. Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression
  33. Inhibition of SLC drug transporter activities by environmental bisphenols
  34. Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin
  35. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
  36. Recent advances in understanding hepatic drug transport
  37. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation
  38. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate
  39. Proteomic Analysis of the Rat Canalicular Membrane Reveals Expression of a Complex System of P4-ATPases in Liver
  40. Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis
  41. Clearance Prediction of HIV Protease Inhibitors in Man: Role of Hepatic Uptake
  42. Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal Supplements
  43. Flagging Drugs That Inhibit the Bile Salt Export Pump
  44. Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [18F]Ciprofloxacin, a Positron Emission Tomography Study in Mice
  45. Functional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate
  46. Protein kinase C-dependent regulation of human hepatic drug transporter expression
  47. Expression and function of placental uric acid transporter GLUT9
  48. Octreotide Inhibits the Bilirubin Carriers Organic Anion Transporting Polypeptides 1B1 and 1B3 and the Multidrug Resistance-Associated Protein 2
  49. Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes
  50. Transporters in the Liver
  51. Impaired uptake of conjugated bile acids and hepatitis b virus pres1‐binding in na + ‐taurocholate cotransporting polypeptide knockout mice
  52. P1194 : Delayed bile acid uptake with metabolic consequences in NA+-taurocholate cotransporting polypeptide knockout mice
  53. Regulation of Human Hepatic Drug Transporter Activity and Expression by Diesel Exhaust Particle Extract
  54. Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes
  55. Drug Transporters in the Central Nervous System
  56. Efflux and uptake transporters involved in the disposition of bazedoxifene
  57. 292: Placental urate transport is GLUT9-mediated and unidirectional
  58. Role of (Drug) Transporters in Imaging in Health and Disease
  59. The effect of organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the antitumor activity of flavopiridol in breast cancer cells
  60. Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney
  61. Bile Salt Transporters
  62. Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS
  63. Rivaroxaban postmarketing risk of liver injury
  64. Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): Impact on growth of ZR-75-1 breast cancer cells
  65. Bile acid disposition by confocal microscopy
  66. Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis
  67. Molecular pathogenesis of chronic cholestatic liver disease: Impact on novel therapeutic approaches
  68. Differential Effects of Membrane Cholesterol Content on the Transport Activity of Multidrug Resistance–Associated Protein 2 (ABCC2) and of the Bile Salt Export Pump (ABCB11)
  69. The Role of Organic Anion Transporters in Diagnosing Liver Diseases by Magnetic Resonance Imaging
  70. Transport of estradiol-17β-glucuronide, estrone-3-sulfate and taurocholate across the endoplasmic reticulum membrane: evidence for different transport systems
  71. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
  72. Organic Anion-Transporting Polypeptides
  73. Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes
  74. Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters
  75. ATP-binding cassette transporters in liver
  76. Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells
  77. Role of skeletal muscle transport systems in statin-induced myotoxicity
  78. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
  79. Characteristics and Functional Relevance of Apolipoprotein-A1 and Cholesterol Binding in Mammary Gland Tissues and Epithelial Cells
  80. ERRATUM: In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
  81. Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
  82. In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
  83. Structure-Based Identification of OATP1B1/3 Inhibitors
  84. Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
  85. The SLCO (former SLC21) superfamily of transporters
  86. Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes
  87. BSEP (ABCB11)
  88. Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes
  89. Role of Membrane Transport in Hepatotoxicity and Pathogenesis of Drug-Induced Cholestasis
  90. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
  91. Physiological and Biochemical Basis of Clinical Liver Function Tests
  92. Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment
  93. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation
  94. Drug interactions with hepatocellular transport systems and acquired forms of liver disease
  95. Genetic variations in bile acid homeostasis are not overrepresented in alcoholic cirrhosis compared to patients with heavy alcohol abuse and absent liver disease
  96. Diverse Functional Properties of Wilson Disease ATP7B Variants
  97. 37 ACTIVATION OF INTESTINAL FGF15 SIGNALING BY INFLAMMATION LEADS TO CHANGES IN HEPATIC BILE ACID METABOLISM AND A TOXIC BILE PROFILE IN DSS TREATED MICE
  98. An Arabidopsis T-DNA Insertion Mutant for Galactokinase (AtGALK, At3g06580) Hyperaccumulates Free Galactose and is Insensitive to Exogenous Galactose
  99. Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice
  100. The emerging role of transport systems in liver function tests
  101. Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene
  102. Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin DReceptor (NR 1I1) variants on fibrosis progression rate in HCV patients
  103. Interaction of bile salts with rat canalicular membrane vesicles: Evidence for bile salt resistant microdomains
  104. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3
  105. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: Relevance for paclitaxel transport
  106. Regulation of drug transporter expression by oncostatin M in human hepatocytes
  107. The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N‐Tera‐2 neurodifferentiation
  108. The Canalicular Bile Salt Export Pump BSEP (ABCB11) as a Potential Therapeutic Target
  109. Pharmacogenetics of drug transporters in the enterohepatic circulation
  110. Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green
  111. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease
  112. Regulation of the expression of the hepatocellular sulfate–oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: A metabolic link between liver and kidney?
  113. 1277 PROTECTIVE EFFECTS OF HEPATIC FXR ON LIPID ACCUMULATION ARE INDEPENDENT OF THE INTESTINAL FXR-FGF15 SIGNAL
  114. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis
  115. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients
  116. Expression of the organic anion transporters OATP1B1, OATP1B3, and OATP2B1 in human liver is affected by genetic and nongenetic factors
  117. Efficient Generation of Multipotent Mesenchymal Stem Cells from Umbilical Cord Blood in Stroma-Free Liquid Culture
  118. How Organic Anions Accumulate in Hepatocytes Lacking Mrp2: Evidence in Rat Liver
  119. Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans
  120. The Human Organic Anion Transporter Genes OAT5 and OAT7 Are Transactivated by Hepatocyte Nuclear Factor-1α (HNF-1α)
  121. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2
  122. The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathophysiology of Bile Formation
  123. Functional Identification of Arabidopsis ATSIP2 (At3g57520) as an Alkaline  -Galactosidase with a Substrate Specificity for Raffinose and an Apparent Sink-Specific Expression Pattern
  124. The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C
  125. Hepatic Transport Mechanisms of Cholyl-l-Lysyl-Fluorescein
  126. The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats
  127. Genetic Determinants of Drug-induced Cholestasis and Intrahepatic Cholestasis of Pregnancy
  128. Correction to “Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter”
  129. 1128 RELAPSING FEATURES OF BILE SALT EXPORT PUMP (BSEP) DEFICIENCY IN TWO PATIENTS SUCCESSFULLY TRANSPLANTED FOR PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2 (PFIC2)
  130. Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction
  131. 1043 THERAPY RESPONSE IN CHRONIC HEPATITIS C PATIENTS IS AFFECTED BY COMMON VITAMIN D RECEPTOR (NR 1I1) POLYMORPHISMS
  132. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history
  133. Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
  134. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice
  135. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis
  136. Differential Regulation of Drug Transporter Expression by Hepatocyte Growth Factor in Primary Human Hepatocytes
  137. Bile acid levels as a host factor affecting antiviral treatment response but not viral replication in hepatitis C patients
  138. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
  139. Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers
  140. Recent insights into the function and regulation of the bile salt export pump (ABCB11)
  141. W1592 Vitamin D3 and Its Nuclear Receptor VDR Regulate the Expression and Activity of the Human Intestinal Proton-Coupled Folate Transporter PCFT
  142. Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6
  143. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters
  144. Canalicular microdomains and bile formation
  145. ABC-transporters are localized in caveolin-1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes
  146. Taurocholate induces preferential release of phosphatidylcholine from rat liver canalicular vesicles
  147. Turning over or turning around: hepatic phosphatidylcholine in the mouse model for progressive familial intrahepatic cholestasis type 3
  148. Pharmacogenetics of OATP ( SLC21 / SLCO ), OAT and OCT ( SLC22 ) and PEPT ( SLC15 ) transporters in the intestine, liver and kidney
  149. Dearterialization of the Liver Causes Intrahepatic Cholestasis due to Reduced Bile Transporter Expression
  150. Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2
  151. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3
  152. Severe Bile Salt Export Pump Deficiency: 82 Different ABCB11 Mutations in 109 Families
  153. Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin 1β
  154. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump
  155. Bosentan Is a Substrate of Human OATP1B1 and OATP1B3: Inhibition of Hepatic Uptake as the Common Mechanism of Its Interactions with Cyclosporin A, Rifampicin, and Sildenafil
  156. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes
  157. Isolation of renal proximal tubular brush-border membranes
  158. Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition
  159. Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain
  160. The organic anion transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin into skate liver
  161. Function of Both Sinusoidal and Canalicular Transporters Controls the Concentration of Organic Anions within Hepatocytes
  162. Multidrug Resistance Exporters
  163. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury
  164. ATP-Dependent Multiple Substrate Transporters
  165. Amino Acid Permeases
  166. Differentiation of Non-Adherent Hematopoietic Stem Cells from Umbilical Cord Blood Cells into Adherent Hepatocytic Lineage.
  167. Twenty years of ATP-binding cassette (ABC) transporters
  168. The bile salt export pump
  169. Genetic Variability, Haplotype Structures, and Ethnic Diversity of Hepatic Transporters MDR3 (ABCB4) and Bile Salt Export Pump (ABCB11)
  170. Characterization of two distinct liver progenitor cell subpopulations of hematopoietic and hepatic origins
  171. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver
  172. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis
  173. Quantitative microscopy reveals 3D organization and kinetics of endocytosis in rat hepatocytes
  174. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation inMdr2+/− mice
  175. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency
  176. Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver
  177. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis
  178. Enterohepatic transport of bile salts and genetics of cholestasis
  179. Magnetic Resonance Imaging With Hepatospecific Contrast Agents in Cirrhotic Rat Livers
  180. Identification and localization of sodium-phosphate cotransporters in hepatocytes and cholangiocytes of rat liver
  181. Differential regulation of basolateral and canalicular transporter expression in rat liver in chronic renal failure
  182. Proteomic analysis of plasma membrane vesicles isolated from the rat renal cortex
  183. Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump
  184. Small hepatocytes in culture develop polarized transporter expression and differentiation
  185. Differential expression of bile salt and organic anion transporters in developing rat liver
  186. Gd-BOPTA Transport Into Rat Hepatocytes: Pharmacokinetic Analysis of Dynamic Magnetic Resonance Images Using a Hollow-Fiber Bioreactor
  187. Metal‐responsive transcription factor‐1 (MTF‐1) is essential for embryonic liver development and heavy metal detoxification in the adult liver
  188. Enterohepatic bile salt transporters in normal physiology and liver disease
  189. Phenobarbital Alters Hepatic Mrp2 Function by Direct and Indirect Interactions
  190. Hepatocyte performance on different crystallographic faces of rutile
  191. Regulation of Rat Organic Anion Transporters in Bile Salt–Induced Cholestatic Hepatitis: Effect of Ursodeoxycholate
  192. Biliary cholesterol secretion: more lessons from plants?
  193. Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway
  194. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat
  195. 827 Polarized transport differentiation of small heptocytes in culture
  196. Physiological characteristics of allo-cholic acid
  197. Functional analysis of candidate ABC transporter proteins for sitosterol transport
  198. Functional expression of the canalicular bile salt export pump of human liver
  199. Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice
  200. Introduction
  201. Structure and function of ABC transporters
  202. Identification of a Novel Human Organic Anion Transporting Polypeptide as a High Affinity Thyroxine Transporter
  203. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride
  204. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy
  205. Bile Salt Transporters
  206. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17β-d-glucuronide in rats
  207. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver
  208. FIC1: another bile salt carrier within the enterohepatic circulation?
  209. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3
  210. Effects of Ursodeoxycholic and Cholic Acid Feeding on Hepatocellular Transporter Expression in Mouse Liver
  211. Tight Junctions in Liver Disease
  212. Metabolism of amiodarone
  213. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver
  214. Microvesicular liver steatosis in rats with carnitine deficiency
  215. Expression of hepatocellular transporters in long-term cultured small hepatocytes
  216. Cholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat Hepatocytes
  217. the benzofurane ring is responsible for hepatic mitochondrial toxicity of amiodarone
  218. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
  219. Development and characterization of an animal model of carnitine deficiency
  220. Functional analysis and androgen-regulated expression of mouse organic anion transporting polypeptide 1 (Oatp1) in the kidney
  221. Development and characterization of an animal model of carnitine deficiency
  222. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
  223. Differential Regulation of Hepatic Bile Salt and Organic Anion Transporters in Pregnant and Postpartum Rats and the Role of Prolactin
  224. Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodarone
  225. Apical endocytosis in rat hepatocytes in situ involves clathrin, traverses a subapical compartment, and leads to lysosomes
  226. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
  227. Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells
  228. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2
  229. Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver
  230. Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles
  231. Molecular Mechanisms in Bile Formation
  232. Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination
  233. Transport Function and Hepatocellular Localization of mrp6 in Rat Liver
  234. Transport Function and Hepatocellular Localization of mrp6 in Rat Liver
  235. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
  236. Hepatic Transport of Bile Salts
  237. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
  238. Hepatocellular uptake of organic cations by the organic anion transporting polypeptides (Oatp1, Oatp2 and OATP-A) and the organic cation transporters (rOCT1 and hOCT1)
  239. Identification and characterization of rat Oatp4, a multispecificorganic anion transporting polypeptide that is closely related torlst-1
  240. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver
  241. Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain
  242. Localization and function of the organic anion–transporting polypeptide Oatp2 in rat liver
  243. Substrate specificity of the rat organic anion transporting polypeptides oapt1, oatp2 and the human OATP
  244. Regulation of Bile Salt Export Pump mRNA Levels by Dexamethasone and Osmolarity in Cultured Rat Hepatocytes
  245. Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient mice
  246. Identification of Thyroid Hormone Transporters
  247. Sodium taurocholate cotransporting polypeptide is a serine, threonine phosphoprotein and is dephosphorylated by cyclic adenosine monophosphate
  248. Partial Maintenance of Taurocholate Uptake by Adult Rat Hepatocytes Cultured in a Collagen Sandwich Configuration
  249. Bile acid and xenobiotic transporters in liver
  250. Characterization of a sodium-dependent transport system for butyrobetaine into rat liver plasma membrane vesicles
  251. The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver
  252. Expression, Distribution, and Activity of Na+,K+-ATPase in Normal and Cholestatic Rat Liver
  253. Organ and cellular distribution of the organic anion transporting polypeptide 2 (oatp2) in rat
  254. Transport properties of the canalicular bile salt transporter or sister of P-glycoprotein
  255. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation
  256. Hepatic bile salt flux does not modulate level and activity of the sinusoidal Na+-taurocholate cotransporter (ntcp) in rats
  257. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas
  258. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
  259. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein
  260. Differential Interaction of Bile Acids from Patients with Inborn Errors of Bile Acid Synthesis with Hepatocellular Bile Acid Transporters
  261. Interaction Between Amiodarone and Lidocaine
  262. Immunologic distribution of an organic anion transport protein in rat liver and kidney
  263. Expression of a rat liver phosphatidylcholine translocator in Xenopus laevis oocytes
  264. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver
  265. Characterization of l-carnitine transport by rat kidney brush-border-membrane vesicles
  266. In situ localization of the hepatocytic na+/taurocholate cotransporting polypeptide in rat liver
  267. Functional characterization of the basolateral rat liver organic anion transporting polypeptide
  268. Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchmal cells
  269. Cloning and functional characterization of a human liver basolateral organic anion transporting polypeptide (OATP)
  270. Apical and basolateral parathyroid hormone receptors in rat renal cortical membranes
  271. Expression cloning of a rat liver Na(+)-independent organic anion transporter.
  272. Expression of a RAT liver canalicular phosphatidylcholine translocator in Xenopus laevis oocytes
  273. Parallel decrease of Na+ -taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes
  274. Molecular properties of the Na+-dependent taurocholate cotransporting polypeptide (Ntcp) of rat liver
  275. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver.
  276. Phylogenic and ontogenic expression of hepatocellular bile acid transport.
  277. 5'nucleotidase is sorted to the apical domain of hepatocytes via an indirect route [published erratum appears in J Cell Biol 1993 Nov;123(3):following 767]
  278. ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles
  279. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.
  280. Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopus laevis oocytes.
  281. Expression cloning of the hepatocyte Na+/bile acid cotransport system
  282. Biogenesis of Endogenous Plasma Membrane Proteins in Epithelial Cells
  283. [20] Transport studies with renal proximal tubular and small intestinal brush border and basolateral membrane vesicles: Vesicle heterogeneity, coexistence of transport systems
  284. A novel marker glycoprotein for the microvillus membrane of surface colonocytes of rat large intestine and its presence in small-intestinal crypt cells.
  285. Dissection of the asynchronous transport of intestinal microvillar hydrolases to the cell surface.
  286. Biogenesis of the rat hepatocyte plasma membrane in vivo: comparison of the pathways taken by apical and basolateral proteins using subcellular fractionation.
  287. Sodium-proton exchange in colon brush-border membranes
  288. Isolation of brush-border membranes from rat and rabbit colonocytes: Is alkaline phosphatase a marker enzyme?
  289. Na/H- and Cl/OH-exchange in rat jejunal and rat proximal tubular brush border membrane vesicles
  290. Demonstration of sodium-dependent, electrogenic substrate transport in rat small intestinal brush border membrane vesicles by a cyanine dye
  291. The application of a potential-sensitive cyanine dye to rat small intestinal brush border membrane vesicles
  292. Transport ofl-cysteine by rat renal brush border membrane vesicles
  293. Transport ofl-cystine by rat renal brush border membrane vesicles
  294. Transport ofl-lysine by rat renal brush border membrane vesicles
  295. A high yield preparation for rat kidney brush border membranes Different behaviour of lysosomal markers
  296. Chapter 2. Drug Transporters in the Liver: Their Involvement in the Uptake and Export of Endo- and Xeno-biotics
  297. Chapter 1. Membrane Transporters: Fundamentals, Function and Their Role in ADME
  298. 1 Physiology of bile formation: Hepatocellular bile salt transporters
  299. 15 Drug-induced cholestatic liver injury
  300. Functions of the Liver